Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today ...

Scientists in China have analyzed the impact of soiling of PV module performance and have found that tilt angle has the ...

Xenon Pharmaceuticals XENE reported a loss of 84 cents per share for the fourth quarter of 2024, narrower than the Zacks ...

William Blair restated their outperform rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a report ...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has earned an average rating of “Buy” from the nine ratings firms that are covering the company, Ratings reports. Nine equities research ...

Recaro has introduced the Xenon 1, a car seat designed to provide superior safety, comfort and convenience for children ages 0-7. Engineered in Germany, the Xenon 1 meets the latest i-Size safety ...

Workers in high-risk work environments need to feel confident their flame-resistant clothing will also help them be seen by ...

“We expect the next 12 to 24 months will represent a catalyst-rich period for Xenon as we continue to advance our deep pipeline of promising late- and early-stage programs across multiple ...

RBC Capital raised the firm’s price target on Xenon Pharmaceuticals (XENE) to $58 from $56 and keeps an Outperform rating on the shares after ...

Wedbush lowered the firm’s price target on Xenon Pharmaceuticals (XENE) to $42 from $43 and keeps an Outperform rating on the shares. Most ...

Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.

BURNABY, British Columbia — BURNABY, British Columbia — Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $65.7 million in its fourth quarter. On a per-share basis, the Burnaby ...